Neuroendocrine and metabolic impairments in patients with Parkinson's disease

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
N I VeruginaE A Lyashenko

Abstract

Neuroendocrine and neurometabolic disorders, although occasionally noted in Parkinson's disease (PD), existed in the shadow of motor and non-motor symptoms (hypokinesia, rigidity, tremor, depression, constipation, etc.). In recent years, they are increasingly being diagnosed and are the subject of special research. These include, in particular, disorders of carbohydrate metabolism, changes in body weight, metabolic disorders in bone tissue, secretion, as well as the secretion of neurohormones, such as melatonin. They are associated with other non-motor symptoms, negatively affect patients' general condition and quality of life, but can be treatable. At the same time, treatment of neuroendocrine and neurometabolic disorders can favorably influence the rate of progression of the disease as a whole. This review discusses the pathophysiological mechanisms, clinical consequences, as well as pharmacological and non-pharmacological approaches to the treatment of neuroendocrine and neurometabolic disorders arising in PD, which have been relatively rarely covered in literature.

References

Nov 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·J J van HiltenR A Roos
Dec 1, 1990·BMJ : British Medical Journal·S LeviA Tomkins
Mar 1, 1993·The International Journal of Neuroscience·R Sandyk
Aug 2, 2002·Clinical Neuropharmacology·Bernard Bruguerolle, Nicolas Simon
Oct 9, 2002·Neurology·R D AbbottH Petrovitch
Feb 26, 2004·Lancet Neurology·Suzanne Craft, G Stennis Watson
Aug 3, 2004·Acta Neurologica Scandinavica·B LorefältA-K Granérus
Feb 21, 2006·Lancet Neurology·K Ray ChaudhuriUNKNOWN National Institute for Clinical Excellence
Dec 13, 2006·Neurology·G HuJ Tuomilehto
Jan 19, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Harold L Newmark, Jonathan Newmark
Apr 4, 2007·Journal of Neurology·Camila Andrade Mendes MedeirosVeralice Meireles Sales de Bruin
May 11, 2007·Brain : a Journal of Neurology·Thomas C ThannickalJerome M Siegel
May 23, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Sebastian PausMichael Abele
Jun 15, 2007·Neurology·K IkedaY Iwasaki
Dec 11, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Markus HerrmannWolfgang Herrmann
Feb 10, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Birgitta LorefältAnn-Kathrine Granérus
Sep 8, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Paul SauleauMarc Vérin
Nov 13, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Zane B AndrewsTamas L Horvath
Jul 14, 2010·Archives of Neurology·Paul KnektMarkku Heliövaara
Dec 4, 2010·Science·Joseph Bass, Joseph S Takahashi
Jan 29, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·N Ahmad AzizRaymund A C Roos
Nov 2, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Klaus SeppiCristina Sampaio
Feb 11, 2012·Current Neurology and Neuroscience Reports·Ilia N Karatsoreos
Feb 22, 2012·Brain : a Journal of Neurology·Iciar Aviles-OlmosThomas Foltynie
Oct 4, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Emanuele CeredaGianni Pezzoli
Jan 16, 2013·Parkinson's Disease·Sonja RuttenYsbrand D van der Werf
Feb 1, 2013·Neuropathology and Applied Neurobiology·M E KalaitzakisR K B Pearce
Feb 8, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Richard W WalkerWilliam K Gray
Mar 7, 2013·Parkinsonism & Related Disorders·Vikas KotagalNicolaas I Bohnen
Apr 27, 2013·Current Opinion in Neurobiology·Aarti JagannathRussell G Foster
May 24, 2013·Chronobiology International·Nicolas CermakianGianluigi Mazzoccoli
May 28, 2013·Current Opinion in Neurobiology·Clifford B Saper
Mar 13, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Kelli M TorsneyAndrew J Lees
Mar 26, 2014·Journal of Parkinson's Disease·Iciar Aviles-OlmosThomas Foltynie
Jun 12, 2014·Frontiers in Neurology·Andrea KistnerPaul Krack
Aug 22, 2014·Lancet Neurology·Amanda J KiliaanDeborah R Gustafson
Oct 5, 2014·Neuroscience·J Mendoza, E Challet
Nov 11, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Paul SauleauMarc Vérin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Indian Journal of Clinical Biochemistry : IJCB
Ashok Panagariya, Vinay Agarwal
Journal of Inherited Metabolic Disease
Jean-Marie Saudubray
Journal of Neurology, Neurosurgery, and Psychiatry
Eduardo De Pablo-FernándezThomas T Warner
© 2021 Meta ULC. All rights reserved